HIV uses autophagy for its own means

Jul 27, 2009
Kyei et al. found that the HIV Gag protein (green) localized to autophagosomes (red). Another HIV protein, Nef, blocks the later stages of autophagosome maturation to allow full Gag processing and increase viral yield. Credit: Kyei, G.B., et al. 2009. J. Cell Biol. doi:10.1083/jcb.200903070

Not satisfied with simply thwarting its host's defensive maneuvers, HIV actually twists one to its advantage, based on new findings from Kyei et al. in the July 27, 2009 issue of the Journal of Cell Biology. Vojo Deretic and colleagues suggest that autophagy—a stress response process—helps HIV to proliferate and that conversely, blocking autophagy lessens HIV production.

Reduced levels were accompanied by a blockade in the processing of Gag—a key precursor protein for HIV assembly. Gag in fact localized to complexes containing an autophagy protein, LC3. "It looked paradoxical," says Deretic. "But only if you didn't know something else. And that is a finding in yeast that autophagy is not only degradative, but can also serve in some biosynthetic pathways," including the trafficking of the Cvt protein to the vacuole. Together, the results suggest that Gag may piggyback on autophagosomes or their components, perhaps for locomotive services, to complete its maturation.

The group then sought the viral agitator that blocks autophagosome maturation and allows Gag processing. Their primary candidate was HIV protein Nef, which interacts with the vacuolar proton ATPase and might thereby block acidification steps necessary to make a degradative organelle. Using a mutant virus, the group showed that HIV lacking Nef no longer profited from increased autophagy and was instead degraded. It is not yet clear exactly how Nef blocks autophagosome maturation.

Clinical applications may be far down the road. If the idea is to kill the virus using drugs such as , which induces autophagy, it will first be necessary to block Nef, notes Deretic. The idea is not without natural support. "There were cases in Australia involving HIV strains that lacked Nef," he says. "And these people would not progress to AIDS, meaning the virus is disabled."

Deretic has other exciting ideas. Highly active anti-retroviral therapy often does a smashing job clearing viral loads from the blood. But the pathogen can persist in particular locales such as gut lymphoid tissue. "My hope," says Deretic, "is to go after these reservoirs and chew up the virus that for some reason is not readily accessible or susceptible to the anti-retroviral therapy. I have great hope that autophagy will help us with that. This is something we didn't have on our radar screens just five years ago."

More information: Kyei, G.B., et al. 2009. J. Cell Biol. doi:10.1083/jcb.200903070 .

Source: Rockefeller University (news : web)

Explore further: Lift U.S. ban on blood donations by gay men, experts say

add to favorites email to friend print save as pdf

Related Stories

Vaccine to cope with viral diversity in HIV

Apr 27, 2007

The ability of HIV-1 to develop high levels of genetic diversity and acquire mutations to escape immune pressures contributes to our difficulties in producing a vaccine. David Nickle et al present here an efficient algorithm ...

Mutant host cell protein sequesters critical HIV-1 element

Jan 15, 2009

Scientists have identified a new way to inhibit a molecule that is critical for HIV pathogenesis. The research, published by Cell Press in the January 16th issue of the journal Molecular Cell, presents a target for develo ...

How HIV hides itself

Apr 01, 2008

Researchers have discovered how Human Immunodeficiency Virus (HIV), which causes AIDS, can hide itself in our cells and dodge the attention of our normal defences, scientists heard today at the Society for General Microbiology’s ...

Scientists find another key to HIV success

Mar 22, 2006

Weill Cornell Medical College scientists say they've determined a protein produced by HIV infected cells prevents immune B cells from producing antibodies.

New target for HIV/AIDS drugs and vaccine discovered

Jul 26, 2007

Researchers from Rome, Italy, describe a finding in the August 2007 print issue of The FASEB Journal that could lead to new drugs to fight the HIV/AIDS virus, as well as new vaccines to prevent infection.

Recommended for you

How we got ahead in HIV control

8 hours ago

When AIDS first emerged in the early 1980s, HIV infection was a death sentence. But a global effort has ensured this is no longer the case for a growing number of people.

User comments : 0